Quantitative interactome analysis reveals a chemoresistant edgotype
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Chemoresistance is a common mode of therapy failure for many cancers. Tumours develop resistance to chemotherapeutics through a variety of mechanisms, with proteins serving pivotal roles. Changes in protein conformations and interactions affect the cellular response to environmental conditions contributing to the development of new phenotypes. The ability to understand how protein interaction networks adapt to yield new function or alter phenotype is limited by the inability to determine structural and protein interaction changes on a proteomic scale. Here, chemical crosslinking and mass spectrometry were employed to quantify changes in protein structures and interactions in multidrug-resistant human carcinoma cells. Quantitative analysis of the largest crosslinking-derived, protein interaction network comprising 1,391 crosslinked peptides allows for ‘edgotype’ analysis in a cell model of chemoresistance. We detect consistent changes to protein interactions and structures, including those involving cytokeratins, topoisomerase-2-alpha, and post-translationally modified histones, which correlate with a chemoresistant phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., & Mann, M. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200025-mcp200 · Cited by 5,574
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Combinatorial patterns of histone acetylations and methylations in the human genome
Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Peng, W., Zhang, M. Q., et al. (2008) · Nature Genetics · doi:10.1038/ng.154 · Cited by 2,331
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity.
Xu, Y., & Villalona-Calero, M. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf337 · Cited by 413
Mass spectrometry supported determination of protein complex structure
Walzthoeni, T., Leitner, A., Stengel, F., & Aebersold, R. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.02.008 · Cited by 146
Tang, X., & Bruce, J. E. (2010) · Molecular BioSystems · doi:10.1039/b920876c · Cited by 143
Self-citationChavez, J. D., Cilia, M., Weisbrod, C. R., Ju, H.-J., Eng, J. K., Gray, S. M., & Bruce, J. E. (2012) · Journal of Proteome Research · doi:10.1021/pr300041t · Cited by 69
Self-citation
Cited by
O’Reilly, F. J., & Rappsilber, J. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0147-0 · Cited by 360
Leitner, A., Faini, M., Stengel, F., & Aebersold, R. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.008 · Cited by 355
Cross-Linking Mass Spectrometry: An Emerging Technology for Interactomics and Structural Biology
Yu, C., & Huang, L. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04431 · Cited by 353
Piersimoni, L., Kastritis, P. L., Arlt, C., & Sinz, A. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00786 · Cited by 314
Caudal, A., Tang, X., Chavez, J. D., Keller, A., Mohr, J. P., Bakhtina, A. A., Villet, O., Chen, H., Zhou, B., Walker, M. A., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00127-4 · Cited by 33
Self-citation
Metadata
- Authors
- Chavez, J. D., Schweppe, D. K., Eng, J. K., Zheng, C., Taipale, A., Zhang, Y., Takara, K., & Bruce, J. E.
- Venue
- Nature Communications
- Published
- 2015-08-03
- Volume
- 6
- Issue
- 1
- Pages
- 7928-7928
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W1066150364
- Cited by
- 94
- References
- 7
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.